Bernd Kirchhof

1985-1985 Doheny Eye Institute - UCLA 
 2001-2017 University of Cologne, Köln, Nordrhein-Westfalen, Germany 
"Bernd Kirchhof"

Kirchhof (born 1952) had accepted the appointment to the chair of his boss Prof. Klaus Heimann, who died in 1999, at the University Eye Clinic in Cologne in January 2001.

Kirchhof had previously held the Aachen Chair of Ophthalmology and was Director of the University Eye Clinic of RWTH Aachen University since 1996, succeeding Prof. Martin Reim. Kirchhof had expanded operative retinology there. During his term of office, outpatient cataract surgery was also introduced in Aachen - driven mainly by Kirchhof's then senior physician Prof. Martin Wenzel.

Kirchhof's clinical and scientific focus is on diseases of the posterior segment of the eye. Recent publications as first or co-author deal with cell transplantation in AMD, diseases of the vitreoretinal interface, silicone oil surgery or the comparison of ocular parameters in former premature or mature newborns.

Kirchhof officially retired on October 1st, but will continue to lead the PRIVENT study as clinical trial leader until his successor is appointed (PRIVENT: Prophylactic intravitreal administration of 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with primary rhegmatogenic retinal detachment).
(Show less)

Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kirchhof B, Rüssmann W, Faschinger C, et al. (2023) [The Second Opinion via Telemedicine in Ophthalmology]. Klinische Monatsblatter Fur Augenheilkunde
Joussen AM, Müller B, Kirchhof B, et al. (2020) Rupture of the Globe: What to Do, What not to Do. Klinische Monatsblatter Fur Augenheilkunde. 237: 1070-1078
Kirchhof B, Joussen A, Bornfeld N, et al. (2020) Prof. Dr. med. Dr. h.c. mult. Gerd Meyer-Schwickerath inventor of light coagulation on his 100th birthday (July 10, 2020). Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 258: 1837-1838
Liakopoulos S, Spital G, Brinkmann CK, et al. (2020) ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD). The British Journal of Ophthalmology
Rizzo S, Barale PO, Ayello-Scheer S, et al. (2019) Hypotony and the Argus II retinal prosthesis: causes, prevention and management. The British Journal of Ophthalmology
Schaffrath K, Schellhase H, Walter P, et al. (2019) One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study. Jama Ophthalmology
Schaub F, Hoerster R, Schiller P, et al. (2018) Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial. Trials. 19: 384
Fieß A, Kölb-Keerl R, Schuster AK, et al. (2018) Correlation of morphological parameters and visual acuity with neurological development in former preterm children aged 4-10 years. Acta Ophthalmologica
Hoerauf H, Kirchhof B. (2017) „Zuwarten“ als therapeutisches Prinzip bei Erkrankungen der vitreoretinalen Grenzfläche Ophthalmologe. 114: 1042-1049
Kirchhof B. (2017) [Cell Transplantation in Age-related Macular Degeneration]. Klinische Monatsblatter Fur Augenheilkunde. 234: 1082-1087
See more...